Elevance Health ROA 2010-2025 | ELV
Current and historical return on assets (ROA) values for Elevance Health (ELV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Elevance Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $5.92B | $119.72B | 5.08% |
| 2024-12-31 | $5.98B | $116.89B | 5.22% |
| 2024-09-30 | $6.42B | $116.53B | 5.70% |
| 2024-06-30 | $6.69B | $112.99B | 6.02% |
| 2024-03-31 | $6.24B | $111.89B | 5.67% |
| 2023-12-31 | $5.99B | $108.93B | 5.47% |
| 2023-09-30 | $6.00B | $110.48B | 5.56% |
| 2023-06-30 | $6.31B | $109.17B | 5.95% |
| 2023-03-31 | $6.09B | $109.04B | 5.86% |
| 2022-12-31 | $5.89B | $102.76B | 5.79% |
| 2022-09-30 | $6.22B | $103.03B | 6.19% |
| 2022-06-30 | $6.13B | $100.88B | 6.17% |
| 2022-03-31 | $6.28B | $100.49B | 6.41% |
| 2021-12-31 | $6.16B | $97.46B | 6.36% |
| 2021-09-30 | $5.52B | $98.06B | 5.86% |
| 2021-06-30 | $4.23B | $96.10B | 4.64% |
| 2021-03-31 | $4.71B | $95.68B | 5.28% |
| 2020-12-31 | $4.57B | $86.62B | 5.32% |
| 2020-09-30 | $4.96B | $86.57B | 5.93% |
| 2020-06-30 | $5.92B | $87.98B | 7.27% |
| 2020-03-31 | $4.78B | $82.40B | 6.10% |
| 2019-12-31 | $4.81B | $77.45B | 6.29% |
| 2019-09-30 | $4.30B | $77.81B | 5.73% |
| 2019-06-30 | $4.07B | $75.85B | 5.50% |
| 2019-03-31 | $3.99B | $74.52B | 5.41% |
| 2018-12-31 | $3.75B | $71.57B | 5.11% |
| 2018-09-30 | $4.56B | $74.45B | 6.23% |
| 2018-06-30 | $4.34B | $74.37B | 6.06% |
| 2018-03-31 | $4.15B | $73.30B | 5.91% |
| 2017-12-31 | $3.84B | $70.54B | 5.57% |
| 2017-09-30 | $2.98B | $68.31B | 4.41% |
| 2017-06-30 | $2.85B | $68.24B | 4.28% |
| 2017-03-31 | $2.78B | $68.94B | 4.23% |
| 2016-12-31 | $2.47B | $65.08B | 3.84% |
| 2016-09-30 | $2.28B | $64.40B | 3.59% |
| 2016-06-30 | $2.32B | $64.06B | 3.68% |
| 2016-03-31 | $2.40B | $63.86B | 3.80% |
| 2015-12-31 | $2.56B | $61.72B | 4.03% |
| 2015-09-30 | $2.89B | $62.34B | 4.55% |
| 2015-06-30 | $2.86B | $64.26B | 4.52% |
| 2015-03-31 | $2.73B | $65.55B | 4.35% |
| 2014-12-31 | $2.57B | $61.68B | 4.15% |
| 2014-09-30 | $2.21B | $62.06B | 3.60% |
| 2014-06-30 | $2.24B | $62.30B | 3.67% |
| 2014-03-31 | $2.31B | $61.69B | 3.82% |
| 2013-12-31 | $2.49B | $59.58B | 4.17% |
| 2013-09-30 | $2.81B | $60.26B | 4.71% |
| 2013-06-30 | $2.84B | $59.61B | 4.86% |
| 2013-03-31 | $2.68B | $59.41B | 4.69% |
| 2012-12-31 | $2.66B | $58.96B | 4.79% |
| 2012-09-30 | $2.53B | $55.82B | 4.70% |
| 2012-06-30 | $2.52B | $54.54B | 4.76% |
| 2012-03-31 | $2.58B | $52.50B | 4.95% |
| 2011-12-31 | $2.65B | $52.16B | 5.13% |
| 2011-09-30 | $2.86B | $52.55B | 5.60% |
| 2011-06-30 | $2.92B | $50.88B | 5.75% |
| 2011-03-31 | $2.94B | $50.92B | 5.81% |
| 2010-12-31 | $2.89B | $50.17B | 5.70% |
| 2010-09-30 | $5.08B | $51.03B | 9.94% |
| 2010-06-30 | $5.07B | $50.16B | 9.99% |
| 2010-03-31 | $5.04B | $51.18B | 9.98% |
| 2009-12-31 | $4.75B | $52.13B | 9.47% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $91.235B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.565B | 26.36 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.719B | 19.73 |
| DiDi Global (DIDIY) | China | $21.932B | 33.29 |
| Natera (NTRA) | United States | $20.928B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $13.109B | 13.88 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.943B | 0.00 |
| CochLear (CHEOY) | Australia | $11.734B | 0.00 |
| Revvity (RVTY) | United States | $11.115B | 19.13 |
| ICON (ICLR) | Ireland | $10.559B | 9.82 |
| Viatris (VTRS) | United States | $10.281B | 3.53 |
| Doximity (DOCS) | United States | $10.038B | 46.76 |
| Avantor (AVTR) | United States | $9.104B | 13.23 |
| Medpace Holdings (MEDP) | United States | $8.794B | 23.36 |
| HealthEquity (HQY) | United States | $8.442B | 41.53 |
| Sonic Healthcare (SKHHY) | Australia | $8.311B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.944B | 13.61 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.201B | 38.89 |
| Bausch + Lomb (BLCO) | Canada | $4.160B | 24.52 |
| Sotera Health (SHC) | United States | $3.616B | 20.55 |
| Alignment Healthcare (ALHC) | United States | $3.213B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.025B | 39.33 |
| Concentras Parent (CON) | United States | $2.892B | 16.71 |
| Organon (OGN) | United States | $2.340B | 2.49 |
| Ardent Health Partners (ARDT) | United States | $2.167B | 9.24 |
| GeneDx Holdings (WGS) | United States | $2.026B | 78.04 |
| Premier (PINC) | United States | $1.903B | 14.44 |
| Progyny (PGNY) | United States | $1.843B | 40.57 |
| PACS (PACS) | United States | $1.623B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.411B | 28.21 |
| Teladoc Health (TDOC) | United States | $1.282B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.277B | 9.72 |
| Establishment Labs Holdings (ESTA) | $1.065B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.986B | 15.39 |
| Nutex Health (NUTX) | United States | $0.981B | 14.82 |
| Agilon Health (AGL) | United States | $0.969B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.858B | 8.04 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.679B | 4.57 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.38 |
| Auna S.A (AUNA) | Luxembourg | $0.524B | 13.88 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.481B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.404B | 0.00 |
| SBC Medicals (SBC) | United States | $0.353B | 0.00 |
| Oncology Institute (TOI) | United States | $0.231B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.211B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |